Re:Cancer is solved: by PD-1/PDL-1 inhibitors
by nanofortnight on Saturday October 13, 2018 @08:06AM
(#18207577)
Improper title.
1. This is specifically about non-SCLC.
2. This article is entirely about a downside to receiving PD-1/PDL-1 inhibitor biologics as immunotherapy; that approximately a third of patients develop HPD and should be switched to salvage chemotherapy as soon as this is noted.
1. This is specifically about non-SCLC.
2. This article is entirely about a downside to receiving PD-1/PDL-1 inhibitor biologics as immunotherapy; that approximately a third of patients develop HPD and should be switched to salvage chemotherapy as soon as this is noted.